baber/WOPTO huggingface dataset:
Patent NZ-509667-A (NZ)
Title: Delivery modification system for radiation therapy
Inventor: FITCHARD EDWARD E
IPC: A61N5/10
Filed: 1999-08-06
Abstract: Radiotherapy controlling, treatment sinograms may be directly modified to correct for real time motion of patients or portions of patients resulting from physiological or other activity. Precalculated partial sinograms representing treatments of portions of a patient may be assembled to obtain a treatment sinogram for the entire patient without delay from conventional planning software. The partial sinograms are modified as representations of their corresponding portions and manipulated to conform to the particular dimensions of an actual patient. This constructed sinogram may be used directly or as a starting point for iterative optimization.
Patent NZ-510287-A (NZ)
Title: 8-azabicyclo[3.2.1]oct-2-ene and -octane derivatives useful as cholinergic ligands at the nicotinic acetyl choline receptor
Inventor: PETERS DAN
IPC: A61P25/28
Filed: 1999-11-26
Abstract: A 8-azabicyclo[3.2.1]oct-2-ene derivative has the formula (I)in labeled or unlabeled form, or an enantiomer or mixture thereof, or a pharmaceutically acceptable salt thereof wherein: R is hydrogen or alkyl and R1 is naphthyl group substituted one or more times by hydroxy, alkoxy, alkoxy-alkyl, alkoxy-alkoxy, alkylcarbonyloxy, halogen, amino, pyyrolidinyl, piperidinyl, piperazinyl or homopiperazinyl. The compounds are useful for treating a disease or disorder responsive to the action of a nicotinic Acetyl Choline Receptor modulator such as a disease or disorder of the central nervous system, a disease or disorder caused by or related to smooth muscle contraction, an endocrine disorder, a disease or disorder caused by or related to neuro-degeneration, a disease or disorder caused by or related to inflammation, pain or a withdrawal symptom caused by the termination of abuse of chemical substances.
Patent NZ-512106-A (NZ)
Title: Signalling of bouquet information in a digital transmission system
Inventor: REY FRANCOIS
IPC: H04H20/00
Filed: 1999-11-05
Abstract: A method of transmission of digital information in a digital communication network, the network comprising at least one transport stream carrying one or more bouquet related tables such as BAT tables (53, 54) containing information regarding the services provided in a commercial bouquet is characterised in transmitting at least one table (51) comprising a list of bouquet identity values of some or all of the bouquet association tables together with an indication of the or each transport stream carrying that table or tables. In a particularly preferred embodiment, the table (51) containing a list of bouquet identity values may correspond to the Network Information Table of a network. The present invention also extends to the identification of any fixed PID, TID tables that may only be distinguished by their TID extension values. The present invention is particularly applicable to digital television systems conforming to the MPEG-2 and DVB proposed standards.
Patent NZ-512800-A (NZ)
Title: An IBDV mutant in a vaccine for poultry
Inventor: MUNDT EGBERT E
IPC: C12N15/09
Filed: 2001-07-05
Abstract: A broad spectrum infectious bursal disease virus (IBDV) vaccine that is able to induce a protective immune response against classical and variant E IBDV strains is described.  The IBDV mutant strain comprises nucleotide sequences encoding a variant E VP2 protein in segment A of the viral genome. The vaccine can be administrated to poultry via mass application routes.
Patent NZ-516228-A (NZ)
Title: Herbicidal emulsifiable concentrates
Inventor: SCHMIDT FRIEDRICH
IPC: A01N25/30
Filed: 2000-06-27
Abstract: The specification relates to a non-aqueous, emulsifiable concentrate formulation (EC) for herbicidal crop protection. The active compounds of this consist essentially of: a) 25 to 150g/L of at least one fluorinated herbicidal compound of the formula I (as shown below) in which R1 and R3 each independently represent a fluorine atom or a fluoroalkyl group, R2 represents a hydrogen atom or an optionally substituted alkyl or alkoxy group and m and n each independently represent an integer from 1-2 b) 400 to 900g/L of one or more herbicidal alkyl phenoxyalkanoates c) 10 to 100g/L of at least one non-ionic surfactant d) 10 to 100 g/L of at least one benzene sulfonate e) 50 to 600g/L of one or more solvent selected from the group consisting of aliphatic or aromatic hydrocarbons, methylated plant oils and water-miscible polar aprotic organic solvents, and f) Optionally, up to 5g/L of a defoamer The above compound can be diluted with water and used for the control of undesired weeds, and for herbicidal crop protection
Patent NZ-517447-A (NZ)
Title: Single-phase process for production of fatty acid methyl esters from mixtures of triglycerides and fatty acids
Inventor: BOOCOCK DAVID GAVIN BROOKE
IPC: C10L1/02
Filed: 2000-08-15
Abstract: A single liquid phase process for the esterification of a mixture of fatty acids and triglycerides, comprising: (a)   Forming  a  solution of fatty acids and triglycerides, an  alcohol,  and  acid  catalyst  and  a  co-solvent  at  a temperature  that  is  less than the boiling  point  of  the solution,   the  alcohol  being  selected  from  the   group consisting of methanol and ethanol or mixtures thereof,  and the  molar  ratio  of the alcohol to the triglycerides  plus one  third of the fatty acids being in the range of 15:1  to 35:1,  the co-solvent being in an amount to effect formation of a single liquid phase; (b)   Permitting acid-catalysed esterification of the  fatty acids to occur; (c)   Neutralising  the  acid catalyst  and  adding  a  base catalyse  for  the transesterification of the triglycerides; and (d)   Permitting  esterification  of  the  triglycerides  to occur and separating ester from the solution.
Patent NZ-519405-A (NZ)
Title: Pre-filled syringe and method for making same
Inventor: ANEAS ANTOINE
IPC: A61M5/28
Filed: 2000-12-07
Abstract: A syringe has a syringe body (2) including an elongate barrel (4) containing a volume of medical fluid (44), one first end forming a hub (16), designed to co-operate with a needle of said syringe, a second end (6) opposite the hub and a plunger (28) mobile relative to said hub. The second end forms a closed base (6) and the plunger (28) is entirely housed inside the barrel (4). Said syringe body is inexpensive, easy to produce, provides satisfactory fluid-tightness and prevents all microbial migration towards the medical fluid.
Patent NZ-524036-A (NZ)
Title: Treatment and diagnosis of cancer
Inventor: BANDER NEIL H
IPC: C07K16/30
Filed: 1997-07-17
Abstract: An antibody or antigen-binding portion thereof which is capable of binding to and being internalized with prostate-specific membrane antigen in cells, such that the antibody or antigen-binding portion can be used to deliver an intracellularly active cytotoxic agent into a prostate specific membrane antigen-expressing cell; kits comprising the antibody or antigen-binding portion; the use of the antibody or antigen-binding portion in the preparation of a medicament for treating, preventing or delaying development of progression of prostate cancer and non-prostate cancer such as renal cancer, urothelial cancer, colon cancer, rectal cancer, lung cancer, breast cancer and metastatic adenocarcinoma to the liver; and methods of detecting cancerous tissue using the antibody or antigen-binding portion. (62) Divided out of 513369
Patent NZ-525680-A (NZ)
Title: Timber pole preservation in the form of a laminate bandage
Inventor: HOLMES HARRY
IPC: A01N59/10
Filed: 2003-05-05
Abstract: A method of manufacturing and using a laminate incorporating a timber preserving compound suitable to protect the buried portion of a timber power pole or the like, by application to the pole in situ after excavating an area around the pole. The compound is made ready for use by removing a release liner from a laminate exposing the compound in the form of a pre-coated preservative mix on a flexible sheet carrier. The pre-coated carrier is offered up to and pressed against the pole surface to locate it over the desired area of the pole. It is left in place during backfilling of the area when the compound is distributed over the area desired for treatment. Also described and claimed is a method of manufacturing a timber preservative dispensing laminate for uniformly applying the timber preservative compound onto the flexible sheet carrier. (61) Addition to 517767
Patent NZ-527747-A (NZ)
Title: Management system for entertainment machines
Inventor: RUTANEN TUOMO
IPC: G07F17/32
Filed: 2002-01-21
Abstract: A management system for use with a plurality of coin operated player operable entertainment machines (2) has a central control device (19) remote from the machines which communicates with the machines (2) at their respective sites via a plurality of communication interface devices and a wireless data link with the machines (2). The wireless data link is established between the machine interface devices and the central control device to transfer data from the machines to the control device and to transmit control signals between the control device and the machines. The central control device is operable to communicate with other devices separate from the central control device and the machines. The wireless data link uses GSM link or SMS messaging. (61) Addition to 527747
Patent NZ-532045-A (NZ)
Title: An aquaculture system including modular building, water treatment, circulation and air temperature control
Inventor: CUMMINS IAN GEOFFREY
IPC: A01K63/00
Filed: 2002-09-12
Abstract: A self-contained aquaculture system (10) comprising a modular building (11) defining a first main chamber (12) for containing fish or marine invertebrates, a second swirl chamber (13) comprising a primary filter communicating with the main chamber (12) for removing solids from the main chamber (12), a drum filter (64) for receiving and filtering water from the swirl chamber (13), a third biological filter chamber (14) beneath the drum filter (64) for receiving water therefrom and a biological filter tank (15). Water is pumped from the third chamber (14) to the biological filter tank (15) for circulation back to the main chamber (12). The building (11) defines an enclosed space over the chambers (12, 13, 14), the temperature of which is controlled by an air-conditioning unit (118). A foam fractionator (30), ultraviolet unit (31) and ozone generator (32) are used for treating the water in the main chamber (12).
Patent NZ-533186-A (NZ)
Title: Clasp for eyeglasses
Inventor: DIETZ DAN L
IPC: G02C5/00
Filed: 2002-11-15
Abstract: An eyeglasses clasp for maintaining eyeglasses on a cloth material. The clasp comprises magnetic means (106, 108) engaged with the eyeglasses temple bars (100, 102) and aligned with the eyeglasses frame body (104) midpoint when the temple bars are closed. The magnets are in attractive magnetic communication when the temple bars are in closed position. The clasp is used by pivoting one of the temple bars into the closed position. The frame body and closed temple bar are then positioned on one side of a clothing material. The second temple bar is the pivoted into the closed position such that it is on the other side of the clothing material. With the temple bars closed, the magnets are in attractive magnetic communication and impart a gripping force on the article of clothing. The gripping force substantially prevents relative movement between the temple bars and the clothing material
Patent NZ-533981-A (NZ)
Title: Systems and apparatus for monitoring vehicles
Inventor: PETERSEN CLARENCE GENE
Filed: 2004-07-07
Abstract: An apparatus for detecting tilting and rollover characteristics of a vehicle trailer or carriage is disclosed. The apparatus includes a measuring means, a computer control means, an audio indicator means and/or a visual display means for alerting a driver as to the rollover status of a vehicle and/or attached trailer unit. The measuring means includes a first accelerometer which is adapted to be mountable on an axle adjacent a left wheel hub and a second accelerometer adapted to be mountable on the axle adjacent a right wheel hub. The accelerometers are configured and arranged, in use, to obtain and forward any one or more lateral and/or vertical and/or longitudinal acceleration measurements to the computer control means. The control means includes a microprocessor suitably programmed and configured to receive the measurement signals in a suitable digital format, and from these signals determine the rollover state of the trailer being monitored, and provide the driver with an audio indicator and/or visual display means for alerting the driver as to the rollover status of the vehicle.
Patent NZ-535942-A (NZ)
Title: Hand-held cordless vacuum cleaner
Inventor: MILLIGAN MICHAEL
IPC: A47L9/16
Filed: 2004-10-14
Abstract: A hand-held vacuum cleaner with a container for the storage of dirt and debris therein. To provide improved efficiency and performance, the hand-held vacuum may employ a primary HEPA filter, a device for swirling a dirt and debris laden air flow and/or a mechanized filter cleaning device. Swirling may be employed to direct entrained dirt and debris in a desired direction relative to the container to slow the rate with which dirt and debris accumulates on the primary filter and/or to centrifugally remove dirt and debris from the air flow. Mechanized cleaning is employed to shake, scrape or otherwise remove accumulated dirt and debris from the primary filter.
Patent NZ-537407-A (NZ)
Title: Anthelmintic oral homogeneous veterinary pastes
Inventor: FREEHAUF KEITH
IPC: A61K31/498
Filed: 2003-06-13
Abstract: An oral homogeneous veterinary paste for the treating, controlling and preventing of endo-and ectoparasite infections in warm-blooded animals or birds, such as horses and household pets is disclosed, wherein the oral veterinary paste consists essentially of praziquantel, ivermectin, antioxidant, colorant, titanium dioxide, a cellulose, hydrogenated castor oil, and glycerol formal. The disclosure further provides for a process of preparing these veterinary pastes and for a method for increasing the bioavailability of the anthelmintic agents contained in the paste in the warm-blooded animal or bird. This oral homogeneous paste achieve a better bioavailability of the two active anthelmintic agents than when the two actives are in suspension and not dissolved.
Patent NZ-542478-A (NZ)
Title: Tubing containment system
Inventor: TREICHEL STEVEN A
IPC: F16L23/00
Filed: 2004-03-24
Abstract: A piping system is disclosed which includes a fluid impermeable sleeve (16) which has an outer surface, an interior surface and a plurality of longitudinal, spaced ribs formed on the interior surface. A fluid carrying tubing (12) positioned internal to the sleeve, and a coupling (18) which has a tubular body having a first end, a second end and an exterior. The first end has interior threads which engage the outer surface of an end of the sleeve, and the second end overhangs the end of the sleeve. A vent opening extends laterally through the body to the exterior for venting fluid from the interior surface of the sleeve. An annular seal extends between the second end of the body and the tubing, where the vent opening is situated between the annular seal and the first end of the body such that fluid from the interior surface of the sleeve is only vented through the vent opening.
Patent NZ-546156-A (NZ)
Title: Methods and systems for improving a search ranking using location awareness
Inventor: GE XIANPING
IPC: G06F17/30
Filed: 2004-09-20
Abstract: A method for ordering documents, comprises receiving a search query; determining a geographic location associated with the query; determining a topic associated with the query; identifying a set of documents based, at least in part, on the query; determining a location sensitivity factor associated with the topic and determining a topical score for each document in the set of documents. The topical score is based at least in part on the query. The method further comprises for each document in the set of documents determining a measure of distance between a geographic location associated with the document and the geographic location associated with the query and then generating a distance score based, at least in part, on the measure of distance and the location sensitivity factor for each document in the set of documents. The location sensitivity factor controls an amount that the distance score changes as a function of the measure of distance. The method further comprises ordering the set of documents as a function of both the topical scores for the set of documents and the distance scores for the set of documents. Also disclosed is a system comprising means such as a server operable to execute the above described method. A method for presenting advertisements relevant to a target document comprises analyzing a target document to identify a topic for the target document and a geographic location associated with the target document; identifying targeting information for a plurality of advertisements; comparing the targeting information to the topic to identify a set of potential advertisements; determining a distance score for at least one advertisement in the set of potential advertisements using a geographic location of an advertiser location associated with the one advertisement and the geographic location associated with the target document; ordering the set of potential advertisements based, at least in part, on the distance score of the at least one advertisement; and presenting at least some of the ordered set of potential advertisements within the target document.
Patent NZ-555514-A (NZ)
Title: High dose ibandronate formulation
Inventor: KAESTLE HANS-G
IPC: A61K31/663
Filed: 2003-08-07
Abstract: A tablet containing as active substance up to 250mg of bisphosphonates or physiologically safe salts or hydrates thereof for oral application, wherein the tablet kernel consists of 30.0 to 36.0% of active substance; 4.0 to 6.0% by weight of binder; 39.6 to 59.4 by weight of filler; 4.5 to 5.5% by weight of disintegrant; 1.8 to 2.2% by weight of lubricant; and 0.9 to 1.1% by weight of flow regulator. The bisphosphonates or physiologically safe salts or hydrates used are alendronate, clodronate, EB-1053, etidronate, ibandronate, incadronate, neridronate, olpadronate, pamidronate, risedronate, tiludronate, YH 529 or zoledronate in the form of the free acid or a pharmaceutically compatible salt or hydrate, particularly the sodium salt.
Patent NZ-560826-A (NZ)
Title: Composition comprising weak acid and particulate L-dopa useful in the treatment of parkinson's disease
Inventor: PETTERSSON ANDERS
Filed: 2006-03-28
Abstract: Disclosed are pharmaceutical compositions that are useful for inter alia the treatment of motor fluctuations in patients receiving L-dopa for the treatment of Parkinson's disease. The compositiions comprise a weakly acidic material and a pharmacologically-effective amount of L-dopa, presented in particulate form upon the surfaces of larger carrier particles.
Patent NZ-561139-A (NZ)
Title: Fresh dairy products with improved microbial stability
Inventor: HONG YEONG-CHING ALBERT
Filed: 2007-09-03
Abstract: Disclosed is a method of manufacturing a dairy product composition that is resistant to microbial growth, the method comprising: providing a dairy product; adding an inorganic acidulant to the dairy product to create an acidified dairy product that has a pH of about 4.5 to about 6.1; and adding a bacteriocin compound such as nisin and an antimicrobial organic acid to the acidified dairy product in amounts effective to provide resistance to microbial growth for at least about 4 weeks under refrigeration conditions for the dairy product composition. Also disclosed is a method of manufacturing a cheese composition that is resistant to microbial growth, the method comprising: combining milk and at least one inorganic acidulant to provide an acidified milk; adding an enzyme to the acidified milk to create curds; incubating the curds; comminuting the curds to create comminuted curds; adding an antimicrobial composition comprising a bacteriocin compound and an antimicrobial organic acid to the comminuted curds; and pressing the comminuted curds to form a finished cheese.
Patent NZ-561402-A (NZ)
Title: A method and apparatus for determining animal relationships
Inventor: MARCH PAUL ANDREW
IPC: A01K11/00
Filed: 2007-03-17
Abstract: A system for determining one or more relationships between animals from a group of animals is disclosed. The system includes a detection system for generating event data indicative of a plurality of detected events that animals are within a defined proximity of each other over a period of time and an analysis means for analysing, using the event data, a frequency of the detected events for the animals to thereby determine if a relationship exists for the animals. The detection system includes a plurality of communication units and each communication unit is associated with one of the animals in the group. Each detected event indicates that communication devices of respective animals were within the defined proximity.
Patent NZ-568317-A (NZ)
Title: Vaccine composition
Inventor: BOUTRIAU DOMINIQUE
IPC: A61P31/04
Filed: 2002-03-28
Abstract: Provided is a multi-valent immunogenic composition for conferring protection in a host against disease caused by Bordetella pertussis, Clostridium tetani, Corynebacterium diphtheriae, Hepatitis B virus, Polio virus and N. meningitidis comprising: a) acellular pertussis components comprising pertussis toxoid and FHA, b) tetanus toxoid, c) diphtheria toxoid, d) Hepatitis B surface antigen, e) Inactivated polio virus, and f) either or both conjugates of a carrier protein and a capsular polysaccharide or oligosaccharide of a bacterium selected from the group N. meningitidis type Y and N. meningitidis type C.
Patent NZ-570846-A (NZ)
Title: Kinase inhibitors and methods of use thereof
Inventor: GRONEBERG ROBERT D
IPC: C07D231/40
Filed: 2007-01-26
Abstract: Disclosed is 1-(3-tert-butyl-1-p-tolyl-1H-pyrazol-5-yl)-3-(5-fluoro-2-(1-(2-hydroxyethyl)-1H-indazol-5-yloxy)benzyl)urea of formula (I) and compounds of formula (II) and (IV). Also disclosed is the process of making a compound of formula (I), a pharmaceutical composition comprising a compound of formula (I) and the use of a compound of formula (I) or the prodrug 2-(5-(2-((3-(3-tert-butyl-I-p-tolyl-IH-pyrazol-5-yl)ureido )methyl)-4-fluorophenoxy)-1 H-indazol-I-yl)ethyl dihydrogenphosphate in the manufacture of a medicament to treat kinase-mediated conditions particularly inflammatory disease, autoimmune disease, destructive bone disorder, proliferative disorder, infectious disease, viral disease or neurodegenerative disease.
Patent NZ-571015-A (NZ)
Title: Use of polynuclear phenolic compounds as stabilisers
Inventor: LANGE ARNO
IPC: C07C215/50
Filed: 2007-02-21
Abstract: Disclosed is the use of polycyclic phenolic compounds which have up to 20 benzene rings per molecule and are obtained by reacting a tetrahydrobenzoxazine of the general formula I, wherein the substituents are as defined in the specification, with one or more of the same or different phenols of the general formula II, wherein the substituents are as defined in the specification, and/or with one or more of the same or different tetrahydrobenzoxazines of the general formula I, as antioxidants for stabilizing inanimate organic material against the action of light, oxygen and heat.